[ RECIPIENT ENTITY RECORD ]

Seagen

VERIFIED NODE ID: 001383 · seagen
R TARGET NODE — CAPITAL RECIPIENT
Seagen
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Seagen
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Seagen is a global biotechnology company that discovers, develops, and commercializes transformative cancer medicines. Based in Washington, the firm is a leader in antibody-drug conjugate technology. It was a primary destination for institutional healthcare capital in one of the largest biotech acquisitions in history.

Capital Influx Log (Transactions)
Date Type Amount
19 May 2026 EQUITY $43.0B